FIDELITY DIGITAL HEALTH ETF Newsroom

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaNov 30 01:35

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity

BenzingaNov 28 04:36

Peering Into Insulet's Recent Short Interest

BenzingaNov 28 02:00

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28 01:16

Unpacking the Latest Options Trading Trends in Intuitive Surgical

BenzingaNov 27 02:16

White House Announced: Biden-⁠Harris Administration Takes Latest Step to Lower Prescription Drug Costs by Proposing Expanded Coverage of Anti-Obesity Medications for Americans With Medicare and Medicaid

BenzingaNov 26 18:51

After Trump's nomination of the FDA commissioner, the supplier of "affordable weight loss drugs" Hims & Hers surged over 20%, reaching an all-time high.

"Hunterbrook Media, the institution that benchmarks against short sellers like Citron, believes that Trump's nomination of Marty Makary as the head of the usa Food and Drug Administration (FDA) could be beneficial for Hims & hers due to this appointment."

wallstreetcnNov 26 07:19

What's Going On With Hims & Hers Health Stock Monday?

BenzingaNov 26 06:16

Hims & Hers Health Shares Are Trading Higher. Strength Has Been Attributed to President-elect Donald Trump's Plans to Nominate Marty Makary to Lead the FDA.

BenzingaNov 26 03:32

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG

Seeking AlphaNov 26 02:58

Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick

Seeking AlphaNov 26 01:46

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday

BenzingaNov 25 23:21

Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?

BenzingaNov 24 23:20

Breaking Down Masimo: 5 Analysts Share Their Views

BenzingaNov 23 01:00

Masimo Analyst Ratings

BenzingaNov 22 23:02 · Ratings

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...

BenzingaNov 22 05:10

Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed

Seeking AlphaNov 22 05:09

Hims & Hers Launches Meal Replacement Bars And Shakes To Enhance Personalized Weight Loss Plans, Offering Comprehensive Nutrition Support For Customers Starting At $110/Month

BenzingaNov 22 01:01

Citi Research's U.S. Equity Strategy Large-Cap Recommendation List

Seeking AlphaNov 22 00:47

Citi Research's 'SMID Value' Rec List – CHWY, FHN, PODD, and More

Seeking AlphaNov 21 02:59